184 related articles for article (PubMed ID: 31846717)
1. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
Siscos SM; Figenshau K; Rajpara A
J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
[No Abstract] [Full Text] [Related]
2. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
3. Mydriasis and anisocoria in a pediatric hyperhidrosis patient with interesting findings in the family cat.
Sandhu M; Eisenstein K
Pediatr Dermatol; 2023 Jan; 40(1):210-211. PubMed ID: 36263444
[TBL] [Abstract][Full Text] [Related]
4. Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
Med Lett Drugs Ther; 2019 Jan; 61(1564):10-11. PubMed ID: 30856158
[No Abstract] [Full Text] [Related]
5. Use of oral glycopyrronium bromide in hyperhidrosis.
Bajaj V; Langtry JA
Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
[TBL] [Abstract][Full Text] [Related]
6. Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Lamb YN
Clin Drug Investig; 2019 Nov; 39(11):1141-1147. PubMed ID: 31571127
[TBL] [Abstract][Full Text] [Related]
7. Unilateral mydriasis due to a topical "anti-sweat" preparation.
Johnson C; Smereck J
J Emerg Med; 2013 Mar; 44(3):673-4. PubMed ID: 23158696
[No Abstract] [Full Text] [Related]
8. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
[TBL] [Abstract][Full Text] [Related]
9. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
10. Mydriasis secondary to use of glycopyrrolate cream.
Radotra A; Baneke A; Paul B
Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169
[No Abstract] [Full Text] [Related]
11. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
Arnold MJ; O'Connor C
Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
[No Abstract] [Full Text] [Related]
12. Our experience of glycopyrrolate 2% cream for axillary hyperhidrosis.
Hale DR; MacKenzie AI; Kavanagh GM
Br J Dermatol; 2014 Jun; 170(6):1373. PubMed ID: 24484220
[No Abstract] [Full Text] [Related]
13. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
[No Abstract] [Full Text] [Related]
14. Dilated pupils caused by topical glycopyrrolate for hyperhidrosis.
Panting KJ; Alkali AS; Newman WD; Sharpe GR
Br J Dermatol; 2008 Jan; 158(1):187-8. PubMed ID: 17944977
[No Abstract] [Full Text] [Related]
15. Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
Pashaei-Marandi A; Assam JH; Arnold A; Lee AG; Bonelli L
Can J Ophthalmol; 2019 Dec; 54(6):e300-e302. PubMed ID: 31836120
[No Abstract] [Full Text] [Related]
16. Dilated Pupil in a Patient With Hyperhidrosis.
Micieli R; Micieli JA
JAMA; 2019 Jul; 322(3):264-265. PubMed ID: 31219503
[No Abstract] [Full Text] [Related]
17. Pharmacologic anisocoria secondary to topical glycopyrronium for axillary hyperhidrosis: an emerging clinical presentation.
Kaufman AR; Gulati S; Curnyn KM
Can J Ophthalmol; 2020 Oct; 55(5):464. PubMed ID: 32735775
[No Abstract] [Full Text] [Related]
18. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
[TBL] [Abstract][Full Text] [Related]
19. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
Yokozeki H; Fujimoto T; Wanatabe S; Ogawa S; Fujii C
J Dermatol; 2022 Jan; 49(1):86-94. PubMed ID: 34636057
[TBL] [Abstract][Full Text] [Related]
20. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
Luh JY; Blackwell TA
South Med J; 2002 Jul; 95(7):756-8. PubMed ID: 12144084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
